Journal (N reporting TSC) | Total (N = 144) | ||||||
---|---|---|---|---|---|---|---|
BMJ (N = 6) | NEJM (N = 34) | Lancet (N = 20) | HTA (N = 84) | ||||
Number of members | n (n/N%) | 3 (50.0) | 20 (58.8) | 16 (80.0) | 71 (84.5) | 110 (76.4) | |
mean (SD) | 5 (2) | 13 (12) | 8 (5) | 8 (6) | 9 (7) | ||
median (IQR) | 5 (3) | 9 (9) | 6 (5) | 6 (5) | 7 (6) | ||
(min, max) | (4, 7) | (4, 52) | (3, 22) | (2, 34) | (2, 52) | ||
Chair indicated | n (n/N%) | 3 (50.0) | 20 (58.8) | 9 (45.0) | 52 (61.9) | 84 (58.3) | |
Expertise of members indicated | n (n/N %) | 1 (16.7) | 10 (29.4) | 4 (20.0) | 51 (60.7) | 66 (45.8) | |
Expertise | Chief investigator | n (n/N%) | 0 (0.0) | 9 (26.5) | 2 (10.0) | 13 (15.5) | 24 (16.7) |
Trial coordinator | n (n/N%) | 0 (0.0) | 1 (2.9) | 0 (0.0) | 5 (6.0) | 6 (4.2) | |
Clinical expert | n (n/N%) | 0 (0.0) | 3 (8.8) | 2 (10.0) | 41 (48.8) | 46 (31.9) | |
Statistician | n (n/N%) | 0 (0.0) | 4 (11.8) | 2 (10.0) | 23 (27.4) | 29 (20.1) | |
PPI representative | n (n/N%) | 1 (16.7) | 2 (5.9) | 0 (0.0) | 36 (42.9) | 39 (27.1) | |
Health economist | n (n/N%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 11 (13.1) | 11 (7.6) | |
Sponsor representative | n (n/N%) | 0 (0.0) | 5 (14.7) | 1 (5.0) | 2 (2.4) | 8 (5.6) | |
Industry representative | n (n/N%) | 0 (0.0) | 1 (2.9) | 0 (0.0) | 1 (1.2) | 2 (1.4) |